HOME >> BIOLOGY >> NEWS
Genome sequences for three deadly parasites provide foundation for new drugs

An international consortium of scientists has unraveled the genomes of three deadly parasites, and these genome sequences will be published in the July 15, 2005, edition of the premier research journal Science. The sequences of these related parasites which cause African sleeping sickness, Chagas disease and leishmaniasis provide a foundation for developing much-needed new drugs to combat these infectious diseases that affect millions of people around the world.

Seattle Biomedical Research Institute (SBRI) researchers Peter Myler, Ph.D., and Ken Stuart, Ph.D., along with scientists at The Institute for Genome Research (TIGR) in Rockville, MD, Wellcome Trust Sanger Institute in the Hinxton, U.K., and the Karolinska Institute in Stockholm, Sweden, led the sequencing efforts and authored the four resulting papers. Myler and Stuart also serve as faculty at the School of Public Health and Community Medicine and the School of Medicine at the University of Washington, with which SBRI has a formal affiliation.

Three of the papers detail the genomes of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major, while a fourth paper offers a comparative analysis of the genome sequences of the parasites. Cumulatively, the papers have nearly 250 authors from 46 organizations representing 21 different countries on six continents. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and The Wellcome Trust provided funding for the sequencing.

Collectively referred to as the "TriTryps" because each pathogen is a trypanosomatid, Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major are the causative agents, respectively, of African sleeping sickness, Chagas disease and leishmaniasis. More than 500 million people are at risk for one or more of these diseases, which represent more than 4 million disability adjusted life years (DALYs), a unit for measuring the global burden of disease.


'"/>

Contact: Lee Schoentrup
lee.schoentrup@sbri.org
206-256-7440
Seattle Biomedical Research Institute
14-Jul-2005


Page: 1 2 3 4

Related biology news :

1. The Cancer Genome Atlas awards funds for technology development
2. DOE Joint Genome Institute secures long-term lease on production genomics facility
3. DOE JGI upgrades its Microbial Genome Analysis System
4. Genome of Clostridium botulinum reveals the background to worlds deadliest toxin
5. Genome Canada, Gnome Qubec and Universit de Montral launch P3G Consortium and CARTaGENE Project
6. Genome of yellow fever/dengue fever mosquito sequenced
7. Genome-wide search unearths surprising clues for diabetes and triglycerides
8. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
9. No pain, DOE Joint Genome Institute gains coveted ergonomics prize with Shake N Plate
10. DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
11. Genome sequencing reveals key to viable ethanol production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... PHOENIX (PRWEB) , ... August 03, 2020 , ... ... the company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to ... its clients to strengthen their laboratory supply chain for more than 10 years. ...
(Date:7/22/2020)... Calif. (PRWEB) , ... July 21, 2020 , ... ... driving digital transformation and innovation in technology and compliance, announces a new solution ... device companies must ensure every layer of their technology stack complies with FDA ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming ... Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. ... what is the most effective way to complete one? Will the study comply ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... (PRWEB) , ... August 12, 2020 , ... ... Inc. (EMMA International), a global leader in FDA compliance consulting has been ... nation’s fastest-growing private companies. The list represents a unique look at the most ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive ... patients may choose which extremities they would like treated. , Several studies have shown ... At R3 International, umbilical cord tissue is obtained from a lab with a long ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing ... announced that they have entered into a strategic partnership whereby Catalent will provide ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech ... Regulatory Solutions, in a one hour live webinar on Thursday, August 13, ... China for drugs and medical devices. Specifically, for medical devices, the NMPA has departments ...
Breaking Biology Technology:
Cached News: